Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Brachytherapy: An overview for clinicians journalArticle 2019 Chargari, C.; Deutsch, E.; Blanchard, P.; Gouy, S.; Martelli, H.; Guerin, F.; Dumas, I.; Bossi, A.; Morice, P.; Viswanathan, A. N.; Haie-Meder, C.
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates journalArticle 2018 Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C.
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al journalArticle 2015 de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J.
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study journalArticle 2016 Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F.
Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC journalArticle 2015 Strullu, M.; Thomas, C.; Le Deley, M. C.; Chevance, A.; Kanold, J.; Bertrand, Y.; Jubert, C.; Dalle, J. H.; Paillard, C.; Baruchel, A.; Lamant, L.; Michel, G.; Brugieres, L.
The 5000% case: a glimpse into the financial issue of lung cancer treatment journalArticle 2016 Remon, J.; Bonastre, J.; Besse, B.
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials journalArticle 2016 Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T.
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis journalArticle 2018 Guerrini-Rousseau, L.; Dufour, C.; Varlet, P.; Masliah-Planchon, J.; Bourdeaut, F.; Guillaud-Bataille, M.; Abbas, R.; Bertozzi, A. I.; Fouyssac, F.; Huybrechts, S.; Puget, S.; Bressac-De Paillerets, B.; Caron, O.; Sevenet, N.; Dimaria, M.; Villebasse, S.; Delattre, O.; Valteau-Couanet, D.; Grill, J.; Brugières, L.
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study journalArticle 2015 Jourdain, A.; Auperin, A.; Minard-Colin, V.; Aladjidi, N.; Zsiros, J.; Coze, C.; Gandemer, V.; Bertrand, Y.; Leverger, G.; Bergeron, C.; Michon, J.; Patte, C.
biospear: an R package for biomarker selection in penalized Cox regression journalArticle 2018 Ternes, N.; Rotolo, F.; Michiels, S.
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival journalArticle 2015 Kapetanakis, N. I.; Uzan, C.; Jimenez-Pailhes, A. S.; Gouy, S.; Bentivegna, E.; Morice, P.; Caron, O.; Gourzones-Dmitriev, C.; Le Teuff, G.; Busson, P.
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort journalArticle 2018 Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A.
[A new classification for meibomian gland diseases with in vivo confocal microscopy] journalArticle 2016 Randon, M.; Liang, H.; Abbas, R.; Michee, S.; Denoyer, A.; Baudouin, C.; Labbe, A.
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead journalArticle 2015 Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C.
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data journalArticle 2018 Zardavas, D.; Te Marvelde, L.; Milne, R. L.; Fumagalli, D.; Fountzilas, G.; Kotoula, V.; Razis, E.; Papaxoinis, G.; Joensuu, H.; Moynahan, M. E.; Hennessy, B. T.; Bieche, I.; Saal, L. H.; Stal, O.; Iacopetta, B.; Jensen, J. D.; O''''Toole, S.; Lopez-Knowles, E.; Barbaraeschi, M.; Noguchi, S.; Azim, H. A.; Lerma, E.; Bachelot, T.; Wang, Q.; Perez-Tenorio, G.; Can de Velde, C. J. H.; Rea, D. W.; Sabine, V.; Bartlett, J. M. S.; Sotiriou, C.; Michiels, S.; Loi, S.
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma journalArticle 2018 Grill, J.; Massimino, M.; Bouffet, E.; Azizi, A. A.; McCowage, G.; Canete, A.; Saran, F.; Le Deley, M. C.; Varlet, P.; Morgan, P. S.; Jaspan, T.; Jones, C.; Giangaspero, F.; Smith, H.; Garcia, J.; Elze, M. C.; Rousseau, R. F.; Abrey, L.; Hargrave, D.; Vassal, G.
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer journalArticle 2016 Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer journalArticle 2015 Nascimento, C.; Borget, I.; Al Ghuzlan, A.; Deandreis, D.; Hartl, D.; Lumbroso, J.; Berdelou, A.; Lepoutre-Lussey, C.; Mirghani, H.; Baudin, E.; Schlumberger, M.; Leboulleux, S.
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer journalArticle 2018 Devarakonda, S.; Rotolo, F.; Tsao, M. S.; Lanc, I.; Brambilla, E.; Masood, A.; Olaussen, K. A.; Fulton, R.; Sakashita, S.; McLeer-Florin, A.; Ding, K.; Le Teuff, G.; Shepherd, F. A.; Pignon, J. P.; Graziano, S. L.; Kratzke, R.; Soria, J. C.; Seymour, L.; Govindan, R.; Michiels, S.
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies journalArticle 2015 Sze, H.; Blanchard, P.; Ng, W. T.; Pignon, J. P.; Lee, A. W.
Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE) journalArticle 2019 Chang, C. P.; Chang, S. C.; Chuang, S. C.; Berthiller, J.; Ferro, G.; Matsuo, K.; Wunsch-Filho, V.; Toporcov, T. N.; de Carvalho, M. B.; La Vecchia, C.; Olshan, A. F.; Zevallos, J. P.; Serraino, D.; Muscat, J.; Sturgis, E. M.; Li, G.; Morgenstern, H.; Levi, F.; Dal Maso, L.; Smith, E.; Kelsey, K.; McClean, M.; Vaughan, T. L.; Lazarus, P.; Ramroth, H.; Chen, C.; Schwartz, S. M.; Winn, D. M.; Bosetti, C.; Edefonti, V.; Garavello, W.; Negri, E.; Hayes, R. B.; Purdue, M. P.; Boccia, S.; Cadoni, G.; Shangina, O.; Koifman, R.; Curado, M. P.; Vilensky, M.; Swiatkowska, B.; Herrero, R.; Franceschi, S.; Benhamou, S.; Fernandez, L.; Menezes, A. M. B.; Daudt, A. W.; Mates, D.; Schantz, S.; Yu, G. P.; Lissowska, J.; Brenner, H.; Fabianova, E.; Rudnai, P.; Brennan, P.; Boffetta, P.; Zhang, Z. F.; Hashibe, M.; Lee, Y. A.
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort journalArticle 2015 Dartois, L.; Gauthier, E.; Heitzmann, J.; Baglietto, L.; Michiels, S.; Mesrine, S.; Boutron-Ruault, M. C.; Delaloge, S.; Ragusa, S.; Clavel-Chapelon, F.; Fagherazzi, G.
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues journalArticle 2016 Martelli, N.; van den Brink, H.; Borget, I.
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement journalArticle 2015 Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer journalArticle 2015 Deutsch, E.; Le Péchoux, C.; Faivre, L.; Rivera, S.; Tao, Y.; Pignon, J. P.; Angokai, M.; Bahleda, R.; Deandreis, D.; Angevin, E.; Hennequin, C.; Besse, B.; Levy, A.; Soria, J. C.
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma journalArticle 2016 Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G.
Postoperative radiotherapy for non-small cell lung cancer journalArticle 2016 Burdett, S.; Rydzewska, L.; Tierney, J.; Fisher, D.; Parmar, M. K.; Arriagada, R.; Pignon, J. P.; Le Pechoux, C.; Group, Port Meta-analysis Trialists
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry journalArticle 2019 Matejcic, M.; Saunders, E. J.; Dadaev, T.; Brook, M. N.; Wang, K.; Sheng, X.; Olama, A. A. A.; Schumacher, F. R.; Ingles, S. A.; Govindasami, K.; Benlloch, S.; Berndt, S. I.; Albanes, D.; Koutros, S.; Muir, K.; Stevens, V. L.; Gapstur, S. M.; Tangen, C. M.; Batra, J.; Clements, J.; Gronberg, H.; Pashayan, N.; Schleutker, J.; Wolk, A.; West, C.; Mucci, L.; Kraft, P.; Cancel-Tassin, G.; Sorensen, K. D.; Maehle, L.; Grindedal, E. M.; Strom, S. S.; Neal, D. E.; Hamdy, F. C.; Donovan, J. L.; Travis, R. C.; Hamilton, R. J.; Rosenstein, B.; Lu, Y. J.; Giles, G. G.; Kibel, A. S.; Vega, A.; Bensen, J. T.; Kogevinas, M.; Penney, K. L.; Park, J. Y.; Stanford, J. L.; Cybulski, C.; Nordestgaard, B. G.; Brenner, H.; Maier, C.; Kim, J.; Teixeira, M. R.; Neuhausen, S. L.; De Ruyck, K.; Razack, A.; Newcomb, L. F.; Lessel, D.; Kaneva, R.; Usmani, N.; Claessens, F.; Townsend, P. A.; Gago-Dominguez, M.; Roobol, M. J.; Menegaux, F.; Khaw, K. T.; Cannon-Albright, L. A.; Pandha, H.; Thibodeau, S. N.; Schaid,
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors journalArticle 2018 Guerrero-Zotano, A.; Stricker, T.; Formisano, L.; Hutchinson, K. E.; Stover, D. G.; Lee, K. M.; Schwarz, L. J.; Giltnane, J. M.; Estrada, M. V.; Jansen, V. M.; Servetto, A.; Gavilá, J.; Pérez-Fidalgo, J. A.; Lluch, A.; Llombart-Cussac, A.; Bayar, M. A.; Michiels, S.; Andre, F.; Arnedos, M.; Guillem, V.; Ruiz-Simon, A.; Arteaga, C. L.
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor journalArticle 2015 Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F.
Modalités de surveillance des patients suivis pour un cancer de la prostate avancé : résultats d’une enquête nationale de pratique journalArticle 2016 Rozet, F.; Roupret, M.; Hennequin, C.; Massard, C.; Blanchard, P.; Le moulec, S.
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials journalArticle 2016 Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T.
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium journalArticle 2017 Bautista, F.; Moreno, L.; Marshall, L.; Pearson, A. D. J.; Geoerger, B.; Paoletti, X.
Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review journalArticle 2016 Gault, N.; Castaneda-Sanabria, J.; Guillo, S.; Foulon, S.; Tubach, F.
[Data sources, the data used, and the modality for collection] journalArticle 2018 Mercier, G.; Costa, N.; Dutot, C.; Riche, V. P.
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models journalArticle 2015 Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial journalArticle 2017 Belin, L.; Kamal, M.; Mauborgne, C.; Plancher, C.; Mulot, F.; Delord, J. P.; Gonçalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Trédan, O.; Ricci, F.; Alt, M.; Loirat, D.; Sablin, M. P.; Paoletti, X.; Servois, V.; Le Tourneau, C.
Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy journalArticle 2016 Gorphe, P.; Matias, M.; Moya-Plana, A.; Tabarino, F.; Blanchard, P.; Tao, Y.; Janot, F.; Temam, S.
Primary cutaneous and subcutaneous Ewing sarcoma journalArticle 2015 Di Giannatale, A.; Frezza, A. M.; Le Deley, M. C.; Marec-Bérard, P.; Benson, C.; Blay, J. Y.; Bui, B.; Judson, I.; Oberlin, O.; Whelan, J.; Gaspar, N.
Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma journalArticle 2017 Conversano, A.; Mazouni, C.; Thomin, A.; Gaudin, A.; Fournier, M.; Rimareix, F.; Bonastre, J.